Keros Therapeutics

Nima Farzan sold 2,625 shares of KROS on 4 June. They now own 9,767 KROS shares, or a 21% holding decrease.

Julius Knowles sold 2,625 shares of KROS on 4 June. They now own 10,958 KROS shares, or a 19% holding decrease.

Alpna Seth sold 2,625 shares of KROS on 4 June. They now own 9,767 KROS shares, or a 21% holding decrease.

Jean Jacques Bienaime bought 1,000 shares of KROS on 15 May. They now own 9,450 KROS shares, or a 12% holding increase.

Jean Jacques Bienaime bought 1,000 shares of KROS on 15 April. They now own 8,450 KROS shares, or a 13% holding increase.

Jean Jacques Bienaime bought 2,000 shares of KROS on 9 March. They now own 7,450 KROS shares, or a 37% holding increase.

Keith Regnante sold 4,739 shares of KROS on 18 February. They now own 39,261 KROS shares, or a 11% holding decrease.

Lorena Raquel Lerner sold 3,873 shares of KROS on 18 February. They now own 31,127 KROS shares, or a 11% holding decrease.

Esther Cho sold 4,745 shares of KROS on 18 February. They now own 39,755 KROS shares, or a 11% holding decrease.

Tomer Kariv sold 4,787,331 shares of KROS on 15 October. They now own 0 KROS shares, or a 100% holding decrease.

Daniel Schneeberger sold 5,389,264 shares of KROS on 15 October. They now own 0 KROS shares, or a 100% holding decrease.

Daniel Schneeberger bought 934,258 shares of KROS on 9 April. They now own 4,392,737 KROS shares, or a 27% holding increase.

Orbimed Advisors LLC sold 250,000 shares of KROS on 13 August. They now own 119,522 KROS shares, or a 68% holding decrease.

Carl L Gordon sold 250,000 shares of KROS on 13 August. They now own 119,522 KROS shares, or a 68% holding decrease.